These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 26335790

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Effectiveness of repeat angiographic assessment in patients designated for radioembolization using yttrium-90 microspheres with initial extrahepatic accumulation of technitium-99m macroaggregated albumin: a single center's experience.
    Dudeck O, Wilhelmsen S, Ulrich G, Löwenthal D, Pech M, Amthauer H, Ricke J.
    Cardiovasc Intervent Radiol; 2012 Oct; 35(5):1083-93. PubMed ID: 21833803
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Incorporating cone-beam CT into the treatment planning for yttrium-90 radioembolization.
    Louie JD, Kothary N, Kuo WT, Hwang GL, Hofmann LV, Goris ML, Iagaru AH, Sze DY.
    J Vasc Interv Radiol; 2009 May; 20(5):606-13. PubMed ID: 19345589
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Characterization of extrahepatic distribution of Tc-99m macroaggregated albumin in hepatic perfusion imaging studies prior to yttrium-90 microsphere therapy.
    Jiang M, Nowakowski FS, Wang J, Heiba S, Zhang Z, Weintraub J, Kim E, Machac J.
    Cancer Biother Radiopharm; 2011 Aug; 26(4):511-8. PubMed ID: 21790309
    [Abstract] [Full Text] [Related]

  • 29. Partition Model-Based 99mTc-MAA SPECT/CT Predictive Dosimetry Compared with 90Y TOF PET/CT Posttreatment Dosimetry in Radioembolization of Hepatocellular Carcinoma: A Quantitative Agreement Comparison.
    Gnesin S, Canetti L, Adib S, Cherbuin N, Silva Monteiro M, Bize P, Denys A, Prior JO, Baechler S, Boubaker A.
    J Nucl Med; 2016 Nov; 57(11):1672-1678. PubMed ID: 27307346
    [Abstract] [Full Text] [Related]

  • 30. Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres.
    Lau WY, Kennedy AS, Kim YH, Lai HK, Lee RC, Leung TW, Liu CS, Salem R, Sangro B, Shuter B, Wang SC.
    Int J Radiat Oncol Biol Phys; 2012 Jan 01; 82(1):401-7. PubMed ID: 20950954
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. 90Y radioembolization dosimetry using a simple semi-quantitative method in intrahepatic cholangiocarcinoma: Glass versus resin microspheres.
    Nezami N, Kokabi N, Camacho JC, Schuster DM, Xing M, Kim HS.
    Nucl Med Biol; 2018 Apr 01; 59():22-28. PubMed ID: 29448165
    [Abstract] [Full Text] [Related]

  • 35. Radioembolization with 90Y resin microspheres for HCC patients with extensive tumor thrombosis into the extrahepatic vessels.
    Ahmadzadehfar H, Pieper CC, Ezziddin S, Biersack HJ, Meyer C.
    Clin Nucl Med; 2014 Mar 01; 39(3):305-7. PubMed ID: 24458185
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. 99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization.
    Wondergem M, Smits ML, Elschot M, de Jong HW, Verkooijen HM, van den Bosch MA, Nijsen JF, Lam MG.
    J Nucl Med; 2013 Aug 01; 54(8):1294-301. PubMed ID: 23749996
    [Abstract] [Full Text] [Related]

  • 38. Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis.
    Garin E, Rolland Y, Edeline J, Icard N, Lenoir L, Laffont S, Mesbah H, Breton M, Sulpice L, Boudjema K, Rohou T, Raoul JL, Clement B, Boucher E.
    J Nucl Med; 2015 Mar 01; 56(3):339-46. PubMed ID: 25678490
    [Abstract] [Full Text] [Related]

  • 39. Evaluation of factors affecting tumor response and survival in patients with primary and metastatic liver cancer treated with microspheres.
    Demirelli S, Erkilic M, Oner AO, Budak ES, Gunduz S, Ozgur O, Bozcuk H, Sindel HT, Boz A.
    Nucl Med Commun; 2015 Apr 01; 36(4):340-9. PubMed ID: 25563137
    [Abstract] [Full Text] [Related]

  • 40. Hepatic falciform ligament Tc-99m-macroaggregated albumin activity on SPECT/CT prior to Yttrium-90 microsphere radioembolization: prophylactic measures to prevent non-target microsphere localization via patent hepatic falciform arteries.
    Kao YH, Tan AE, Khoo LS, Lo RH, Chow PK, Goh AS.
    Ann Nucl Med; 2011 Jun 01; 25(5):365-9. PubMed ID: 21234723
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.